CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

GDUFA IV: Fiscal Years 2028 – 2032

RegulatoryNeutral
AI Analysis

Summary

FDA announces preparation for the fourth reauthorization of GDUFA, which will cover fiscal years 2028-2032. This is a routine regulatory announcement with details to be published as they become available.

Outcome Details

FDA preparing for fourth reauthorization of GDUFA covering fiscal years 2028-2032

Importance:2/10
Sentiment:
0.00
GDUFAFDAReauthorizationGeneric Drug User Fee Amendment

Read the original article

Published by FDA Drugs (New Approvals & NDA) on March 3, 2026 9:26 PM

Read Original